Radiopharm Theranostics Limited (RADX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Radiopharm Theranostics L...

    NASDAQ: RADX · Real-Time Price · USD
    6.77
    0.57 (9.19%)
    At close: Oct 06, 2025, 11:03 AM

    Radiopharm Theranostics Balance Sheet Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q4 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Jun 30, 2022
    Cash & Equivalents
    		 36.44M 18.58M 1.89M 11.7M 26.98M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a
    Long-Term Investments
    		 40K 40K 40K n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a 40K 40K
    Receivables
    		 6.25M 987.41K 4.41M 4.47M 56.48K
    Inventory
    		 n/a n/a n/a n/a n/a
    Other Current Assets
    		 n/a 3.29M 163.77K 133.13K 228.82K
    Total Current Assets
    		 44.35M 22.85M 6.47M 16.3M 27.26M
    Property-Plant & Equipment
    		 57.1K 60.8K 64.44K 68.33K 1.58K
    Goodwill & Intangibles
    		 48M 49.09M 56.72M 58.54M 56.08M
    Total Long-Term Assets
    		 48.1M 49.19M 56.83M 58.65M 56.12M
    Total Assets
    		 92.45M 72.04M 63.29M 74.95M 83.38M
    Account Payables
    		 3.14M 6.43M 9.02M 2.96M 1.19M
    Deferred Revenue
    		 3.16M n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Current Liabilities
    		 2.65M 6.72M 3.83M 8.11M 5.73M
    Total Current Liabilities
    		 13.15M 17.58M 12.84M 13.23M 7.88M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 27.3M 27.11M 26.11M 16.14M 12.54M
    Total Long-Term Liabilities
    		 27.3M 27.11M 26.11M 16.14M 12.54M
    Total Liabilities
    		 40.45M 44.68M 38.95M 29.37M 20.42M
    Total Debt
    		 n/a n/a n/a n/a n/a
    Book Value
    		 n/a n/a n/a n/a n/a
    Book Value Per Share
    		 n/a n/a n/a n/a n/a
    Common Stock
    		 168.28M 100.68M 99.06M 97.23M 86.76M
    Retained Earnings
    		 -127.79M -111.34M -89.03M -65.35M -30.82M
    Comprehensive Income
    		 11.86M 37.93M 14.2M 10.36M 7.03M
    Shareholders Equity
    		 53.2M 28.12M 24.23M 44.38M 62.96M
    Total Investments
    		 40K 40K 40K n/a n/a

    Add to Watchlist